CC
IBB icon

Codex Capital’s iShares Biotechnology ETF IBB Stock Holding History

Codex Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$247K Hold
1,800
– – 0.12% 37
2023
Q4 		$245K Buy
1,800
+300
+20% +$36.6K 0.14% 37
2023
Q3 		$183K Hold
1,500
– – 0.12% 37
2023
Q2 		$190K Hold
1,500
– – 0.12% 37
2023
Q1 		$194K Hold
1,500
– – 0.13% 37
2022
Q4 		$197K Hold
1,500
– – 0.16% 37
2022
Q3 		$176K Hold
1,500
– – 0.15% 37
2022
Q2 		$205K Hold
1,500
– – 0.13% 37
2022
Q1 		$205K Hold
1,500
– – 0.13% 36
2021
Q4 		$228K Hold
1,500
– – 0.12% 41
2021
Q3 		$242K Hold
1,500
– – 0.13% 41
2021
Q2 		$246K Buy
+1,500
New +$231K 0.13% 41

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Codex Capital's IBB Position: Q1 2024 in Review

Codex Capital held its iShares Biotechnology ETF (IBB) position steady in Q1 2024 at 1,800 shares worth $247K. The position accounts for 0.12% of the portfolio, ranked #37.

Codex Capital first reported a position in IBB in Q2 2021 and has held it in 12 quarters since. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

  • Codex Capital held 1,800 shares of iShares Biotechnology ETF worth $247K as of Q1 2024.
  • Codex Capital left its iShares Biotechnology ETF share count unchanged in Q1 2024.
  • iShares Biotechnology ETF made up 0.12% of Codex Capital's portfolio in Q1 2024, its #37 holding.
  • Codex Capital first reported a position in iShares Biotechnology ETF in Q2 2021 and has held it in 12 quarters since.
  • 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Codex Capital's 13F filing for Q1 2024, filed 7 May 2024.